For prepackaged contraceptives when dispensing legend drugs not factory by an LSP, what must be disclosed?

For prepackaged contraceptives when dispensing legend drugs not factory by an LSP, what must be disclosed?

• A. Name, address, and phone number of the person in charge
• B. Name, address, phone number, and title of the person in charge
• C. Only the clinic's contact information
• D. Only the prescriber's contact information

Answer: (B)

When a legend drug is dispensed in a prepackaged form that isn’t manufactured by the dispensing facility, there needs to be clear accountability and a direct point of contact. The required disclosure identifies who is in charge at the dispensing site and provides their contact information, including their title. This ensures patients, regulators, and the facility can reach the responsible person quickly and understands the authority behind the dispensing. Name, address, phone number, and the title of the person in charge establish who is legally responsible for the product and who can address questions or concerns about the dispensing. Providing only the clinic’s contact information or only the prescriber’s contact fails to designate the specific individual in charge within the dispensing operation, and omitting part of the contact information would hinder appropriate follow-up or regulatory oversight.

When a legend drug is dispensed in a prepackaged form that isn’t manufactured by the dispensing facility, there needs to be clear accountability and a direct point of contact. The required disclosure identifies who is in charge at the dispensing site and provides their contact information, including their title. This ensures patients, regulators, and the facility can reach the responsible person quickly and understands the authority behind the dispensing. Name, address, phone number, and the title of the person in charge establish who is legally responsible for the product and who can address questions or concerns about the dispensing.

Providing only the clinic’s contact information or only the prescriber’s contact fails to designate the specific individual in charge within the dispensing operation, and omitting part of the contact information would hinder appropriate follow-up or regulatory oversight.